Unit of Molecular Therapies, Department of Experimental Oncology, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy.
Cell Cycle. 2010 Feb 1;9(3):557-63. doi: 10.4161/cc.9.3.10554.
Yin Yang 1 (YY1), a multifunctional transcription factor, has been shown to be involved in the pathogenesis of several cancer types. However, its role in hematological malignancies has not yet been fully investigated. In the present study, using computational methods, we showed that YY1 transcript levels were significantly increased in the high-grade lymphomas, including Burkitt's lymphoma and diffuse large B-cell lymphoma (DLBCL), compared with those of both low-grade lymphomas and normal B-cells. The significant increase in gene expression resulted in a significant increase also at protein level in three NHL cell lines. The association of YY1 expression with some clinical-pathological features in DLBCL showed a positive correlation between a high level of YY1 mRNA and high levels of BCL-6 protein. Moreover, by analyzing the large series of DLBCL in the Hummel dataset, we identified the transcription factor PAX-5 among the top 50 genes positively correlated with YY1. These findings are also supported by the biological network analysis in which the top network, with the highest score, associated with YY1 expression levels in DLBCL is cellular movement, hematological system development and function, and immune response. overall these data suggest that YY1 is involved in B cells transformation which gives rise to high-grade lymphomas through a dysregulation in the normal development of B cells affecting cell cycle and cellular motility.
阴阳 1(YY1),一种多功能转录因子,已被证明参与了几种癌症类型的发病机制。然而,其在血液恶性肿瘤中的作用尚未得到充分研究。在本研究中,我们使用计算方法表明,与低级别淋巴瘤和正常 B 细胞相比,高级别淋巴瘤(包括伯基特淋巴瘤和弥漫性大 B 细胞淋巴瘤(DLBCL))中的 YY1 转录本水平显着增加。基因表达的显着增加也导致三种 NHL 细胞系中的蛋白水平显着增加。YY1 表达与 DLBCL 中某些临床病理特征的关联表明,YY1 mRNA 水平高与 BCL-6 蛋白水平高之间存在正相关。此外,通过分析 Hummel 数据集的大型 DLBCL 系列,我们确定了转录因子 PAX-5 是与 YY1 呈正相关的前 50 个基因之一。这些发现也得到了生物学网络分析的支持,其中与 DLBCL 中 YY1 表达水平相关的最高网络,得分最高,与细胞运动、血液系统发育和功能以及免疫反应有关。总的来说,这些数据表明,YY1 通过干扰 B 细胞的正常发育而参与 B 细胞转化,从而导致高级别淋巴瘤的发生,影响细胞周期和细胞运动。